FDA Adverse Event Injury Summary report: N

OMNIPOD 5 AUTOMATED INSULIN DELIVERY SYSTEM

MDR report key: 19526545 · Received June 13, 2024

Report

Report Number
3004464228-2024-22024
Event Type
Injury
Date Received
June 13, 2024
Date of Event
May 22, 2024
Report Date
June 13, 2024
Manufacturer
INSULET CORPORATION
Product Code
QFG
UDI-DI
10385083000138
PMA / PMN Number
K203768
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE SKIN IRRITATION/INFECTION. NO LOT RELEASE RECORDS WERE REVIEWED, AS THE PRODUCT LOT NUMBER WAS NOT PROVIDED. THE OMNIPOD IS ISO10993 COMPLIANT, UNDERGOING CYTOTOXICITY, SENSITIZATION, GENOTOXICITY, HEMOLYSIS, IRRITATION OR INTRACUTANEOUS REACTIVITY, SYSTEMIC TOXICITY, AND IMPLANTATION EFFECTS TESTING. THE OMNIPOD IS STERILIZED WITH 100% ETHYLENE OXIDE GAS WITH A STERILITY ASSURANCE LEVEL OF 10-6  PER ISO11135  AND EO RESIDUAL LEVELS IN COMPLIANCE WITH ISO10993. EACH LOT  IS CONFIRMED TO MEET REQUIREMENTS FOR NON-PYROGENICITY PER ISO10993 AND STERILITY PER ISO11135 PRIOR TO RELEASE.

Description of Event or Problem · 0

AN MHRA USER REPORT 2024/005/022/501/020 MHRA REF: 30762193-AICXML HAS BEEN RECEIVED REPORTING THE FOLLOWING "DEVICE IS CAUSING A SIGNIFICANT SKIN IRRITATION, DESPITE BARRIER SPRAY (WITH WHICH CHILD DOES NOT HAVE A REACTION). THIS HAS THEN CAUSED A SECONDARY SKIN INFECTION."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1124619 OMNIPOD 5 AUTOMATED INSULIN DELIVERY SYSTEM ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG INSULET CORPORATION PT-000438 10385083000138

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown